We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Latest Generation Immunoassay Analyzer to Be Displayed at AACC Annual Meeting

By LabMedica International staff writers
Posted on 02 Aug 2016
A large capacity, robust, yet simple-to-use chemiluminescence immunoassay analyzer will be presented at the 2016 AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA).

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. More...
(Shenzhen, China) will have the CL-1000i chemiluminescence immunoassay analyzer on display in Booth 2027 at the Philadelphia expo.

The CL-1000i is a robust yet simple-to-use chemiluminescence immunoassay analyzer. It offers a large capacity of 25 reagents, six sample racks, and supports non-stop replacement of reagents and consumables during testing. By integrating reliable chemiluminescence immunoassay technology with the latest in electrical and intuitive software improvements, CL-1000i reduces the complexity of laboratory operations and enhances diagnostic confidence. Currently Mindray offers 49 immunoassay tests for use with analyzer, with more to come in the near future.

Mindray has been a leading medical devices provider in the areas of patient monitoring and life support, in-vitro diagnostics, and medical imaging system for more than 25 years. In the in vitro diagnostics field, Mindray offers solutions for laboratories with different test volume requirements for hematology, biochemistry, chemiluminescence immunoassay, hemoglobin, flow cytometry, coagulation, and others.

Related Links:
AACC Annual Meeting & Clinical Lab Expo
Shenzhen Mindray Bio-Medical Electronics

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.